CN · Field Sheet
FIELD SHEET — REISHI MFI-REISHI-20261019-FS
Survey index / REISHI

Reishi.

Ganoderma lucidum, Ganoderma lingzhi
Polypore mushroom; immune, fatigue and adjunct-oncology literature.
SEALED MFI-REISHI-20261019-FS · RELEASED 2026-10-19
SHEET FINGERPRINTMFI-REISHI-20261019-FS
227INCLUDED
1,721EXCLUDED
84DUPLICATE
41NON-TRANSFERABLE
5OUT OF CUTOFF
Survey totalsScroll ↓
2,078records surveyed
227studies
23claims graded
55observations
6,805graph nodes

Claim records

2 shown · bounded preview
RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-02a723e79fff44a8GRADE VERY_LOW
reishi constituents — antioxidant
direction BENEFIT · dose 100 mg/kg; 400 mg/kg · duration 30 weeks
Grade basis — weakest-link ceilings
VERY_LOWdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
5bound studies
Bound studies (4 shown of 5)
STU-2588131327bac4ac
IN_VITRO · IN_VITRO · 2026 · RoB INSUFFICIENT_INFORMATION
2 endpoints
STU-48f0da1bd672645a
ANIMAL · ANIMAL · 2015 · RoB INSUFFICIENT_INFORMATION
2 endpoints
STU-888c32a7bf5b9203
ANIMAL · ANIMAL · 2023 · 30 weeks · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-d141c8f2e5da3251
ANIMAL · ANIMAL · 2019 · RoB INSUFFICIENT_INFORMATION
4 endpoints
Quantitative observations
observation 400 mg/kg · validated
observation 30 weeks · failed extraction
observation p < 0.01 · validated
Opposition screen
SCREEN · 10 candidates considered · 3 bound as opposing
SYNTHESIS SYN-ec1b270ea5e4ae — outcome QUALITATIVE_ONLY · BENEFIT ×5 · not_assessed_quantitatively · 5 members
PROVENANCE → epmc:41657122, crf:10.1111/acer.12758, epmc:38290027 · PKG 761ccf3440385d22…
CLAIM · CLM-24994f5ebc37fc8aGRADE VERY_LOW
reishi constituents — liver
direction BENEFIT · dose 100 mg/kg; 400 mg/kg · duration 30 weeks; 84 days
Grade basis — weakest-link ceilings
MODERATEdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
4bound studies
Bound studies (4 shown of 4)
STU-48f0da1bd672645a
ANIMAL · ANIMAL · 2015 · RoB INSUFFICIENT_INFORMATION
2 endpoints
STU-4f34711c52407c23
RCT · HUMAN · 2023 · 84 days · RoB SOME_CONCERNS
3 endpoints
STU-888c32a7bf5b9203
ANIMAL · ANIMAL · 2023 · 30 weeks · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-d141c8f2e5da3251
ANIMAL · ANIMAL · 2019 · RoB INSUFFICIENT_INFORMATION
4 endpoints
Quantitative observations
observation 400 mg/kg · validated
observation 30 weeks · failed extraction
observation p < 0.01 · validated
Opposition screen
SCREEN · 6 candidates considered · 1 bound as opposing
SYNTHESIS SYN-189fd16ed698c0 — outcome QUALITATIVE_ONLY · BENEFIT ×4 · not_assessed_quantitatively · 4 members
PROVENANCE → crf:10.1111/acer.12758, epmc:36766186, epmc:38290027 · PKG 761ccf3440385d22…
Bounded preview — representative records only. The full release ships 23 claims and 55 observations.